FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAnteris Technologies Ltd
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
AVR.AX
Anteris Technologies Ltd Stock AnalysisComprehensive stock analysis for Anteris Technologies Ltd (AVR.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisAVR.AX
AVR.AX
Anteris Technologies Ltd
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
AVR.AX
  1. Home
  2. Stocks
  3. Anteris Technologies Ltd

Anteris Technologies Ltd

🇦🇺AVR.AX•ASX

Anteris Technologies Ltd

🇦🇺AVR.AX•ASX

Your view on AVR.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Anteris Technologies Ltd

Industry
Medical - Devices
Sector
Healthcare
CEO
Wayne Geoffrey Paterson
Headquarters
Toowong Tower, Level 3, Suite 302, 9 Sherwood Road, Toowong, QLD, AU
Industry
Medical - Devices
Sector
Healthcare
CEO
Wayne Geoffrey Paterson
Headquarters
Toowong Tower, Level 3, Suite 302, 9 Sherwood Road, Toowong, QLD, AU
Description

Anteris Technologies Ltd is a firm specializing in the structural heart domain. It is responsible for the production and distribution of ADAPT, a product based on regenerative tissue technology.

The company is also actively involved in advancing DurAVR™, an innovative 3D single-component aortic valve specifically designed for treating aortic stenosis. Additionally, Anteris allocates resources to the research and development of regenerative medicines.

Founded in 1999, the enterprise was formerly known as Admedus Limited until it rebranded to Anteris Technologies Ltd in May 2020. Its primary operations are conducted from its base in Toowong, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Anteris Technologies Ltd. Starting points for Anteris Technologies Ltd: EPS -AUD 0.81, beta 0.73 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Anteris Technologies Ltd. Anteris Technologies Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Anteris Technologies Ltd. Trailing twelve-month EPS for Anteris Technologies Ltd stands at -AUD 0.81. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent QtrMar 2027Next QtrSep 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate−$0.35−$0.30−$1.61−$1.72
Low estimate−$0.35−$0.30−$1.84−$1.78
High estimate−$0.35−$0.30−$1.37−$1.66
No. of analysts1122
Year-ago EPS−$0.381−$2.031−$2.611—
Growth————

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrMar 2027Next QtrSep 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$291886.00$1.17M$5.20M$3.79M
Low estimate$291886.00$1.17M$4.59M$3.35M
High estimate$291886.00$1.17M$5.77M$4.21M
No. of analysts1134
Year-ago revenue$404901.00$1.29M$1.91M—
Growth−27.9%−9.8%+171.7%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Anteris Technologies Ltd. Anteris Technologies Ltd has reported as a listed company since 2004. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold AVR.AX15 companies
Compare AVR.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
ARX.AXAroa Biosurgery LimitedHealthcareMedical - Devices—
PNV.AXPolyNovo LimitedHealthcareMedical - Devices—
TTX.AXTetratherix Ltd.HealthcareBiotechnology—
More Medical - Devices companies
TickerTypeCompanySectorExchangeMkt cap
CBLLCeriBell, Inc.HealthcareNASDAQ$995.3M
CERSCerus CorporationHealthcareNASDAQ$391.8M
CGHCCapital Group Holdings, Inc.HealthcareOTC$9,220
CHEOFCochlear LimitedHealthcareOTC$8.9B
CHEOYCochlear LimitedHealthcareOTC$9.2B
CHYPFHealth Logic Interactive Inc.HealthcareOTC$165,839
CLLKFBICO Group AB (publ)HealthcareOTC$123.3M
CLPTClearPoint Neuro, Inc.HealthcareNASDAQ$247.1M
CLVSFCellaVision AB (publ)HealthcareOTC$378.0M
CMP.AXCompumedics LimitedHealthcareASX—
CNMDCONMED CorporationHealthcareNYSE$1.4B
CNVIFConavi Medical Corp.HealthcareOTC$20.7M
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Anteris Technologies Ltd. Coverage tracks Anteris Technologies Ltd within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Anteris Technologies Ltd.

AVR.AX AnalysisFair
Past
5
Growth
1
Health
5
Profit
1
Value
1

News

Latest Market News